Skip to main content
Global Bioenergies logo

Global Bioenergies — Investor Relations & Filings

Ticker · ALGBE ISIN · FR0011052257 LEI · 969500H46XRAMTMVB676 PA Manufacturing
Open in API
Filings indexed 443 across all filing types
Latest filing 2023-03-29 Share Issue/Capital Cha…
Country FR France
Listing PA ALGBE

About Global Bioenergies

https://www.global-bioenergies.com/?lan…

Global Bioenergies develops and commercializes a process to convert renewable resources, such as plant-based sugars and agricultural waste, into isobutene. The company's proprietary technology utilizes fermentation and synthetic biology to produce this key hydrocarbon, which serves as a platform molecule for various applications. The bio-isobutene can be converted into ingredients for the cosmetics industry, specialty chemicals, and renewable fuels. A primary strategic focus is the production of Sustainable Aviation Fuel (SAF) to support the decarbonization of the aviation sector. The process provides a bio-based alternative to petroleum-derived hydrocarbons, aiming to reduce CO2 emissions and dependence on fossil fuels.

Recent filings

Filing Released Lang Actions
Résultat de l’augmentation de capital avec maintien du droit préférentiel de souscription pour un montant brut de 5,6 millions d’euros
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated March 29, 2023, detailing the results of a capital increase ('augmentation de capital avec maintien du droit préférentiel de souscription'). It specifies the amount raised (€5.6 million), the subscription period, the allocation of new shares, and the intended use of the funds. This content directly relates to fundraising, financing activities, and changes in capital structure. This aligns perfectly with the definition for 'Capital/Financing Update' (CAP). It is not an Annual Report (10-K), an Earnings Release (ER), or a simple announcement of a report (RPA), as it contains the substantive results of the financing event itself.
2023-03-29 French
Result of capital increase with preferential subscription rights in a gross amount of €5.6 million
Capital/Financing Update Classification · 98% confidence The document is a press release dated March 29, 2023, announcing the 'Result of capital increase with preferential subscription rights' which raised €5.6 million. It details the subscription demand, allocation of new shares, impact on shareholding structure, and use of proceeds. This clearly relates to a corporate financing activity, specifically a capital raise/share issuance. This aligns directly with the definition for 'Capital/Financing Update' (CAP) or potentially 'Share Issue/Capital Change' (SHA). Since the core subject is the successful completion and results of a capital increase (a financing event), CAP is highly appropriate. SHA focuses more on the mechanics of the share change itself, while CAP covers the overall fundraising event and its purpose. Given the detailed financial context of the capital raise, CAP is the best fit, although SHA is also very close. I will select CAP as it encompasses the financing aspect.
2023-03-29 English
€6.2 million in funding allocated by ADEME to Global Bioenergies’ Prénidem project
Capital/Financing Update Classification · 98% confidence The document is a press release dated March 14, 2023, announcing that Global Bioenergies and its partners have received €6.2 million in funding from ADEME (French government agency) for the Prénidem project. This announcement details a specific financing event, including the amount, the nature of the funding (subsidy/repayable advances), and the project goals. This clearly falls under the category of updates on company fundraising or financing activities, matching the definition for Capital/Financing Update (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it concerns a specific capital event.
2023-03-14 English
Financement de 6,2 millions d’euros attribué par l’ADEME au projet Prénidem mené par Global Bioenergies
Capital/Financing Update Classification · 95% confidence The document announces that Global Bioenergies, in partnership with Ajinomoto Foods Europe and ARD, has received financing (6.2 million euros, composed of grants and repayable advances) from ADEME (the French Agency for Ecological Transition) for the 'Prénidem' project, which focuses on producing bio-sourced isobutene. This is a specific announcement regarding funding and a strategic project, not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS). It details a financing activity and project update. The closest fit among the provided definitions is 'Capital/Financing Update' (CAP), as it explicitly concerns the allocation of funds to the company for a specific project.
2023-03-14 French
Global Bioenergies lance une augmentation de capital avec maintien du droit préférentiel de souscription d’un montant de 7,5 millions d’euros
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated March 6, 2023, announcing the launch of a capital increase ('augmentation de capital') with preferential subscription rights ('droit préférentiel de souscription' or DPS) for a gross amount of 7.5 million euros. It details the subscription price, parity, timelines for trading rights and subscription, and outlines the intended use of proceeds. This clearly falls under the category of financing activities and capital structure changes. Therefore, the appropriate filing type is 'Capital/Financing Update' (CAP). The document is a detailed announcement, not just a brief notice of publication (RPA/RNS), and it is not a full annual report (10-K) or an interim report (IR).
2023-03-06 French
Global Bioenergies launches €7.5 million capital increase with preferential subscription rights
Share Issue/Capital Change Classification · 99% confidence The document is an announcement titled 'Global Bioenergies launches €7.5 million capital increase with preferential subscription rights'. It details the subscription price, ratio, subscription periods, and the purpose of raising capital. This content directly relates to fundraising, financing activities, and changes in the capital structure. This aligns perfectly with the definition for Capital/Financing Update (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it describes a specific corporate financing event.
2023-03-06 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.